Core Viewpoint - Hefei China Resources Shenlu Pharmaceutical Co., Ltd. has received approval for the ancient classic formula preparation Jichuan Jian Granules, marking the third classic formula new drug approved in the province since 2024, indicating a significant period of achievement in the field of classic formula inheritance and innovation transformation [1] Group 1 - Jichuan Jian Granules is derived from the Ming Dynasty text "Complete Works of Zhang Jingyue" and is included in the "Directory of Ancient Classic Formulas (First Batch)," with benefits for warming the kidneys, benefiting essence, and relieving constipation, suitable for kidney deficiency and constipation [1] - The provincial drug regulatory authority included this product in the innovative drug service list during its development application, implementing a three-level linkage service mechanism to address key challenges such as controlling medicinal material origins, optimizing production processes, and establishing quality standards [1] Group 2 - The successful approval of multiple ancient classic formula preparations exemplifies the integrated model of "supervision + service" promoted by the provincial drug regulatory authority, providing replicable and promotable experience for the subsequent transformation of traditional Chinese medicine new drugs [1] - The provincial drug regulatory authority will continue to focus on the inheritance and innovative development of traditional Chinese medicine, improve the long-term mechanism for the research and transformation of classic formulas, and enhance policy support and technical guidance for innovative Chinese medicine enterprises to empower the high-quality development of the Chinese medicine industry [1]